Sepsis Clinical Trial
Official title:
Quality Improvement in Infection COntrol and Sepsis Management in MOdel Regions / Deutsches Qualitaetsbuendnis Sepsis (German Quality Network Sepsis)
The German Quality Network Sepsis is an association trying to improve quality of care for
patients with sepsis, severe sepsis and septic shock or being in risc thereof.
The icosmos trial investigates the impact on the use of routine data, a risk adjustment
algorithm and feedback to all hospitals as well as a structured implementation for regular
screening for deteriorating patients, and education on in-hospital mortality.
All German hospitals provide a set of routine data to federal adminsitration for
reimbursement. This dataset includes all ICD-10-Codes (German adaption) as well as all
procedure codes.
This dataset is pseudonomized and risk adjusted for every individual case and afterwards
feedbacked to each participating hospital including all accumulated data from all other
hospitals as well as the German Average for sepsis mortalities provided by the German Federal
Institute of Statistcs for benchmarkings.
Based on this data, the icosmos trial will provide support to all participating hospitals for
two major strategies to be implemented
1. An algorithm for structured analysis of
1. low-risk-fatalities as potentially preventable deaths for underlying problems in
diagnosis, treatment, etc
2. high-risk-survivors as "best practice"
3. coding errors for improvement of coding quality
2. a structured sreening program of every patient on every ward in every shift for
deterioration and support algorithms including consiliary support and outreach teams as
well as structured education
The icosmos trial will investigate the effects as well on quality of coding and sepsis
incidence as well as on sepsis-related sepsis in-hospital mortality for participating
hospitals in comparison to the German Average.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |